In this study, we aimed to investigate the potential anticancer effects of lercanidipine on cancer cell lines, particularly in combination with cisplatin, and to examine its possible impact on parameters such as cell viability (MTT), proliferation, MAPK pathway activity, caspase enzyme levels, and TNF-α. This evidence concerns the gene TNF and cancer.